Literature DB >> 25591198

Surveillance of the adult cancer survivor.

Jason Wilbur1.   

Abstract

The term "cancer survivor" refers to anyone living with a diagnosis of cancer. As the U.S. population ages, cancer screening increases, and cancer treatments improve, millions more Americans will be classified as cancer survivors in the future. Although many survivors wish to continue care with their oncologists, patients benefit from care provided by a family physician. Many survivors are older and have comorbidities, which should be addressed to optimize function and longevity. Common late effects of cancer and its treatment include second primary cancers, sexual dysfunction, and psychosocial issues. Cancer recurrence is a significant concern. After treatment for colorectal cancer, intensive surveillance, including colonoscopy, imaging, and serology, confers an overall survival benefit. Breast cancer survivors should receive annual mammography. Prostate cancer survivors should undergo prostate-specific antigen testing every six to 12 months. Melanoma survivors should be counseled on sun protection, including daily sunscreen use, and recognizing characteristics of potentially malignant skin lesions. Female survivors of Hodgkin lymphoma who were treated with chest or axillary radiation between 10 and 30 years of age are at high risk of breast cancer, and should be screened with mammography and magnetic resonance imaging annually starting eight to 10 years after the diagnosis. All cancer survivors treated with chest radiation are at increased risk of cardiovascular disease, and should be screened for other cardiovascular risk factors and treated as indicated.

Entities:  

Mesh:

Year:  2015        PMID: 25591198

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  8 in total

1.  Are cancer survivors following the national comprehensive cancer network health behavior guidelines? An assessment of patients attending a cancer survivorship clinic.

Authors:  Kelly A Hyland; Jamie M Jacobs; Inga T Lennes; William F Pirl; Elyse R Park
Journal:  J Psychosoc Oncol       Date:  2018 Jan-Feb

2.  Cancer Survivorship Care Plan Utilization and Impact on Clinical Decision-Making at Point-of-Care Visits with Primary Care: Results from an Engineering, Primary Care, and Oncology Collaborative for Survivorship Health.

Authors:  SarahMaria Donohue; James E Haine; Zhanhai Li; David A Feldstein; Mark Micek; Elizabeth R Trowbridge; Sandra A Kamnetz; James M Sosman; Lee G Wilke; Mary E Sesto; Amye J Tevaarwerk
Journal:  J Cancer Educ       Date:  2019-04       Impact factor: 2.037

3.  Community-Engaged Research to Address Health Disparities of Indigenous Women With Disabilities.

Authors:  Heather J Williamson; Julie S Armin; Ellen Stakely; Bonny Nasimi; Darold H Joseph; Jon Meyers; Julie A Baldwin
Journal:  Ann Int Occup Ther       Date:  2021-05-21

4.  Second primary cancers in long-term survivors of glioblastoma.

Authors:  Jung-Young Kim; Jennifer G Jackman; Sarah Woodring; Frances McSherry; James E Herndon; Annick Desjardins; Henry S Friedman; Katherine B Peters
Journal:  Neurooncol Pract       Date:  2019-02-04

5.  Anxiety-Related Issues in Cancer Survivorship.

Authors:  Maresi A Berry-Stoelzle; Anna C Mark; Peter Kim; Jeanette M Daly
Journal:  J Patient Cent Res Rev       Date:  2020-01-27

6.  Development of second primary cancer in Korean breast cancer survivors.

Authors:  Hong Kyu Jung; Suyeon Park; Nam Won Kim; Jong Eun Lee; Zisun Kim; Sun Wook Han; Sung Mo Hur; Sung Young Kim; Cheol Wan Lim; Min Hyuk Lee; Jihyoun Lee
Journal:  Ann Surg Treat Res       Date:  2017-12-01       Impact factor: 1.859

7.  Are rare cancer survivors at elevated risk of subsequent new cancers?

Authors:  Dianne M Finkelstein; Nora K Horick; Ritesh Ramchandani; Kristina L Boyd; Huma Q Rana; Brittany L Bychkovsky
Journal:  BMC Cancer       Date:  2019-02-21       Impact factor: 4.430

8.  Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study.

Authors:  Danbee Kang; Sang Eun Yoon; Dongwook Shin; Jin Lee; Yun Soo Hong; Se Kyung Lee; Jeong Eon Lee; Yeon Hee Park; Jin Seok Ahn; Eliseo Guallar; Won Seog Kim; Jungho Lee; Seok Jin Kim; Juhee Cho
Journal:  Blood Cancer J       Date:  2021-12-14       Impact factor: 11.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.